Physician profile
Alfonso Mejia
NPI 1043274962
$24,494.09
in general payments reported to CMS, 2019-2025
13 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,706 · 2020: $6,959 · 2021: $6,092 · 2022: $7,221 · 2023: $465 · 2024: $221 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107 · Travel and Lodging: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.64 |
| Travel and Lodging | $409.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $16,805.54 | 2020-2023 | |
| Axogen | $3,980.32 | 2020-2025 | |
| Trimed, INC. | $1,936.83 | 2019 | |
| Acumed LLC | $757.92 | 2019-2024 | Acumed, Innate Implant, Nanophix Implant |
| Zimmer Biomet Holdings, INC. | $437.37 | 2019-2023 | |
| Skeletal Dynamics INC | $165.69 | 2019-2024 | Geminus, Implate, Align |
| Amgen INC. | $114.39 | 2025 | |
| Checkpoint Surgical, INC | $68.43 | 2020 | |
| Stryker Corporation | $63.04 | 2024 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Depuy Synthes Sales INC. | $59.64 | 2025 | Na, Va-Lcp |
| Integra Lifesciences Corporation | $43.09 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $40.00 | 2023 | Evos |
| Medartis INC. | $21.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Mejia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.